Close collaboration with government vital for semiconductor industry to stay resilient: Alvin Tan
Minister of State for Trade and Industry Alvin Tan said that the semiconductor MNCs and SME suppliers should work together to strengthen supply chains.
SINGAPORE – Local semiconductor companies need to work hand in hand with the Government to help the industry stay resilient amid global uncertainty, noted Minister of State for Trade and Industry Alvin Tan on July 10.
Mr Tan said a close collaboration with policymakers will allow the sector, which relies heavily on global – and increasingly vulnerable – supply chains, to focus on new growth areas in order to navigate choppy waters.
These areas include diversifying beyond chip manufacturing, such as in packaging and software design, and creating new traineeships and research partnerships.
Mr Tan told an event organised by the Singapore Semiconductor Industry Association (SSIA) at the Grand Copthorne Waterfront Hotel: 'Singapore's history is long intertwined with the semiconductor industry.'
He added that the sector must go 'glocal' to offset supply chain disruptions. This would involve multi-nationals building networks of local small and medium-sized enterprises (SME) that can capitalise on opportunities to expand overseas and in turn strengthen supply chains.
'This strong synergy across the entire semiconductor supply chain creates new jobs and opportunities for our SMEs,' noted Mr Tan.
He cited three key areas where the Government is investing to future-proof the industry: Intelligent manufacturing; sustainability; and supply chain resilience.
The Government launched the National Semiconductor Translation and Innovation Centre (NSTIC) for Gallium Nitride on June 26 to focus on advanced semiconductors for 5G and 6G communications systems and satellites.
Another $500 million fabrication facility under the NSTIC is expected to be operational in 2027, while artificial intelligence (AI) centres of excellence are in the pipeline to boost the technology's adoption among semiconductor companies.
This initiative will be underpinned by an agreement between the SSIA, Nanyang Polytechnic and the national Artificial Intelligence Singapore programme signed on July 10 to groom talent in AI engineering fields for the semiconductor industry.
Global players are also ramping up expansion here. Taiwan's United Microelectronics Corp opened its facility in Pasir Ris on April 1, while American giant Micron Technology is building a $8.9 billion plant to be opened in 2026.
The high level of trust in the strong ecosystem here makes the Singapore brand a compelling one, said Mr Tan, but the country must keep strengthening its competitive advantage in the face of global disruptors and emerging neighbouring countries.
The semiconductor sector contributes around 6 per cent of Singapore's GDP and is a crucial global player, accounting for 10 per cent of all chips produced worldwide.
A Frost and Sullivan report presented at the SSIA event identified a lack of advanced capabilities and regional competitors as threats to Singapore's industry, while high labour costs and the heavy reliance on imported materials could make it unsustainable in the long term.
The impact of US tariffs on Singapore exports still loom over the semiconductor sector, with negotiations on the levies yet to commence.
Mr Tan noted that the Government is working towards a solution: 'We are studying the impact of tariffs on the semiconductor industry closely, and taking the feedback from companies, SSIA and SME industry associations very carefully for our deliberations.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
11 hours ago
- Straits Times
China can buy Nvidia H20 chips again. But it's not all good news
Sign up now: Get ST's newsletters delivered to your inbox The Cyberspace Administration of China on July 31 flagged concerns about possible 'backdoor' security risks associated with the H20 chips, which American chipmaker Nvidia has denied. – Two weeks after Nvidia's chief executive Jensen Huang mounted a charm offensive to court the Chinese market, the American chip giant found itself once again the centre of attention in Beijing – and not in a good way. 'Nvidia, how can I trust you?' So read the headline of a commentary published by the People's Daily, the communist party's mouthpiece, a day after Chinese regulators summoned on July 31 the company's representatives over what they deemed 'serious security issues' related to its chips. The processor in question, known as the H20, was until recently the most advanced chip that Nvidia could sell to China under US restrictions. Washington effectively banned their exports in April amid an escalating trade war, but said in July that it would allow sales to resume. Some US officials touted the easing of export controls as a negotiating chip in ongoing trade talks with Beijing. But this apparent concession, analysts say, is not necessarily all good news for China. 'The reversal of the H20 ban offers short-term relief for China's artificial intelligence (AI) industry,' said Mr Charlie Dai, a vice president and principal analyst at advisory firm Forrester Research. 'On the other hand, it could slow domestic chipset adoption and impact the pace of technology self-reliance (amid) ongoing geopolitical frictions.' A taste for Nvidia China has been advocating the use of homegrown chips by its companies as part of a broader push for self-reliance, including in key technologies such as AI. Top stories Swipe. Select. Stay informed. Singapore LTA, Singapore bus operators reviewing Malaysia's request to start services from JB at 4am Singapore Despite bag checks and warnings, young partygoers continue to vape in clubs in Singapore Singapore President Tharman meets migrant workers who saved driver of car that fell into sinkhole Singapore Now flying solo, Acres CEO Kalaivanan Balakrishnan presses ahead with wildlife rescue efforts Opinion The charm – and drawbacks – of living in a time warp in Singapore Business UMS Integration becomes first SGX company with secondary listing in Malaysia Singapore Ong Beng Seng to plead guilty on Aug 4, more than 2 years after trip to Qatar with Iswaran Business Decoupling to save on tax? You may lose right to property if ties go awry Despite this, many Chinese AI firms – in particular private tech giants – are said to still prefer using Nvidia's H20s to train and run their models, even though the chips are not Nvidia's most powerful. After the US announced a lifting of its export ban, news agency Reuters reported that Chinese companies were scrambling to buy the H20s, citing sources. It also said that Nvidia had placed fresh orders for 300,000 chipsets from its contract manufacturer amid strong Chinese demand. 'The general sense is that Chinese customers, especially Bytedance, Baidu, Tencent and Alibaba, still prefer Nvidia's solutions, whether it's H20 or whatever comes next,' said Mr Ray Wang, research director for semiconductors, supply chain and emerging tech at advisory firm The Futurum Group. Nvidia's edge over its Chinese rivals – which 'continue to improve' – is manifold for now, he explained. Its hardware has larger memory bandwidth, making it better for inference tasks, or the application of trained AI models that makes them useful in the real world. The company also has a stronger software platform with which to program the chips, as well as more capable networking technology to harness the combined performance of hundreds and thousands of processors, Mr Wang said. Importantly, he added, Chinese firms' rivalry with Huawei – seen as the biggest domestic rival to Nvidia on the chip front – also fuels their preference for the American chipmaker. Huawei has a sprawling business empire that boasts not just chipsets, but also extends to cloud computing and AI model development. This puts them in direct competition with the other tech giants. Mr Wang said: 'So if you're Alibaba or Tencent, do you want to source your most important computing resources from Huawei?' The push for self-reliance Nvidia's current advantages notwithstanding, analysts say that China will simultaneously double down on growing its domestic chip ecosystem – a goal that could be helped by regulators' recent scrutiny of the American firm. The Cyberspace Administration of China had on July 31 flagged concerns about possible 'backdoor' security risks associated with the H20 chips, which Nvidia has denied . A People's Daily commentary released on social media the next day sketched out possible 'nightmare' scenarios associated with such risks, such as electric cars suddenly losing power on the highway. It asked the company to provide proof of the chips' security to alleviate users' worries. The regulators' move 'will likely cause Chinese tech firms to temporarily curb adoption (of the H20) due to fears of potential vulnerabilities and regulatory uncertainty, despite strong underlying demand,' said Mr Dai of Forrester Research. He added that even as companies' continued reliance on Nvidia's superior AI capabilities may sustain some purchases of its chips, he expected firms to simultaneously also accelerate shifts towards domestic alternatives. Mr Su Lian Jye, chief analyst at technology research firm Omdia, said that Chinese firms in recent years had already been buying more homegrown chipsets or developing their own amid sharpening geopolitical tensions. These include China's three major telcos, banks, cloud service providers, and various other state-linked companies, he said. Tech giants including Baidu and Alibaba are also developing their own chips. In recent weeks, following news that Nvidia would once again be allowed to ship H20s to China, local firms have spoken up about strengthening support for homegrown chipmakers. On July 25, AI start-up StepFun, a model developer, announced an 'ecosystem innovation alliance' with several domestic chip companies including Huawei, Cambricon, Moore Threads and MetaX, news outlet Caixin reported. The same day, StepFun released a large language model that was developed with the properties of domestic chips in mind, the report also said. Separately, co-founder of cyber-security company Qihoo 360 Zhou Hongyi said on July 23 that his company had turned to procuring domestic chips, and that its recent purchases had all been of Huawei products, news outlet Yicai reported. The company, which has also branched into AI, is on the US' entity list, which restricts access to American technology. Mr Zhou acknowledged that there was a 'gap' between Chinese chips and Nvidia's, but stressed the need to use domestic processors anyway, in comments that were videoed and uploaded to social media. 'If you don't use them, the gap will always be there,' he said. 'The more (you) use them, the more they will improve.'


AsiaOne
2 days ago
- AsiaOne
South Korea says it has no written pact on US trade deal, Asia News
SEOUL - There is no written agreement yet on a trade deal between South Korea and the United States announced by President Donald Trump this week, the Asian nation's trade minister said on Friday (Aug 1). The US tariff on South Korean imports will be 15 per cent, Trump said after meeting its ministers on Wednesday, down from a threatened 25 per cent, but the US gave scarce details, apart from social media posts by him and Commerce Secretary Howard Lutnick. Speaking to reporters as he arrived home from a visit to Washington, Trade Minister Yeo Han-koo said the two sides had an oral negotiation because of time constraints. "What we felt during this negotiation is that the US trade environment is fundamentally changing. This is completely different from the first Trump term," Yeo said of the deal easing tension with a top-10 trading partner and key Asian ally. "I think we are entering a new normal era. So, although we have overcome this crisis, we cannot be relieved, because we do not know when we will face pressure from tariffs or non-tariff measures again." The White House, which issued factsheets on trade deals with Japan and the European Union a day after striking them, has not yet released a separate one on the pact with South Korea. Trump said South Korea would invest $350 (S$450 billion) billion in the United States in projects "owned and controlled by the United States" and selected by him. Lutnick said 90 per cent of profits from the investments would go to the American people, while White House Press Secretary Karoline Leavitt said they would go to the US government to help repay debt. More discussions were necessary on the investment fund's profit structure, said Industry Minister Kim Jung-kwan, who returned with Yeo. [[nid:720806]] Finance Minister Koo Yun-cheol, also one of the negotiation team, said detailed plans for the $350-billion investment would need be established. Wednesday's deal did not tackle most non-tariff barriers discussed during working-level talks, as well as security and foreign exchange aspects.


International Business Times
2 days ago
- International Business Times
Trump Demands Drug Price Cuts in Letters to 17 Pharma Giants Summary
US President Donald Trump has sent letters to 17 major pharmaceutical companies demanding they cut prescription drug prices in the United States. The letters, released Thursday by the White House, outline his plan to match U.S. prices with those in other developed countries. President Donald Trump addessses the nation after U.S. bombed Iran's nuclear facilities X Trump recently signed an executive order requiring drugmakers to offer "most-favored-nation" pricing. This means companies must sell medications to U.S. patients at the lowest price they offer elsewhere. If drug companies do not comply, Trump warned the government could import cheaper alternatives or take other steps. Companies that received the letters include Pfizer, Eli Lilly, Johnson & Johnson, Merck, Sanofi, and AstraZeneca. Trump had previously criticized earlier proposals from the industry, saying they prioritized profits over patient care. He also demanded that drugmakers return any excess profits made by raising prices overseas to compensate American taxpayers. Shares of major pharmaceutical firms fell after the announcement. Pfizer, Eli Lilly, and Gilead each dropped by around 2%, while a broader index of drug stocks declined 3%. Trump also suggested a system where companies can sell drugs directly to patients, bypassing middlemen, but only if they agree to international pricing rules. The president gave drugmakers a deadline of September 29 to respond with binding commitments. Health experts are skeptical that companies will meet Trump's demands. Some analysts believe the proposals are unlikely to result in immediate price changes, describing them as more political pressure than enforceable policy. Still, several companies, including Pfizer and Novartis, said they are open to working with the administration. Pfizer confirmed its ongoing talks with Trump officials to improve access and affordability for U.S. patients. U.S. drug prices remain among the highest in the world, with patients often paying nearly three times more than those in other developed countries. Drugmakers argue that sharp price cuts could harm innovation, but Trump insists bold action is needed to protect Americans from high costs.